Cardiology

Study: Type 2 diabetes pill Jardiance cuts risk of death

Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.

Oncology & Cancer

Staying one step ahead of cancer cells

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials. In a study published in Nature today, a team of researchers at the Research Institute of Molecular ...

Medications

Hikma buys US generic drugmaker Roxane for $2.65bn

London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector's latest rapid round of consolidation.

Medications

Esbriet, ofev approved to treat deadly lung disease

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

Diseases, Conditions, Syndromes

Raising awareness of covert killer: pulmonary fibrosis

Despite claiming an estimated 40,000 lives annually - roughly the same number as breast cancer or prostate cancer - pulmonary fibrosis remains one of the least known covert killers in the country.

Medications

Journal raises concern about blood-thinning drug

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

page 4 from 5